CT1812 slowed cognitive decline by 95% in Alzheimer’s disease patients with lower levels of plasma p-tau217 in a pre-specified analysis from ...

For more information, or to sign-up to volunteer, go to https://www.concernedforthehungry.org. Fall-La-Palooza event aims to ...

Ms. Ricciardi concluded: "In addition to the substantial progress we have made with CT1812 in Alzheimer's disease, we expect to report top-line results from our Phase 2 SHIMMER study in ...

There are already millions of Dementia Friends in England and Wales! Students who complete the activities will be awarded a badge and a poster for their school. Available for Key Stage 1, 2, 3 and 4.

"Dementia with Lewy Bodies: Filling the Gaps in Translational and Clinical Research." This prestigious workshop, sponsored by the NIA and the National Institute of Neurological Disorders and Stroke ...

Dementia researchers have discovered that an amino acid which was previously thought to help with cognition and memory may ...

AbbVie has an exclusive option to globally develop and commercialize AL002. Alector will deliver a data package resulting ...

The platform presentation entitled, “The MSA Atrophy Index: A Marker of Clinical Progression in Multiple System Atrophy”, was presented by Paula Trujillo Diaz, PhD, Research Assistant Professor, ...

An unnamed 45-year-old man posted an Ask Me Anything (AMA) thread on Reddit discussing the struggles his wife faces after ...

A PDF copy of the poster presentation is available on the "Presentations ... About the RewinD-LB Phase 2b Study in Dementia with Lewy Bodies CervoMed's ongoing Phase 2b study, RewinD-LB, is a ...

Enrolled 4 patients in Cohort 2 of the upliFT-D trial for FTD-GRN, with patient dosing advancing as planned; 12-month Cohort 1 and interim Cohort ...

How millions of cricket fans in India wished they suffered from a temporary spell of dementia, following the nightmarish ...